![Tak Mukohira](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tak Mukohira
Corporate Officer/Principal chez MITSUBISHI TANABE PHARMA CORPORATION
Profil
Mr. Tak Mukohira is President at MP Healthcare Venture Management, Inc. Prior to joining MPH, He worked with Mitsubishi Tanabe Pharma Corporation (MTPC).
For more than 25 years, Mr. Mukohira has assumed broad responsibilities for R&D planning and coordination, alliance management, international operations, mergers and acquisitions, and new business development.
Mr. Tak Mukohira graduated from Kyoto University, Faculty of Pharmaceutical Sciences, and MIT Sloan School of Management-RPh, SM in MOT.
Postes actifs de Tak Mukohira
Sociétés | Poste | Début |
---|---|---|
MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Anciens postes connus de Tak Mukohira
Sociétés | Poste | Fin |
---|---|---|
MP Healthcare Venture Management, Inc.
![]() MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | President | - |
Formation de Tak Mukohira
Kyoto University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
MP Healthcare Venture Management, Inc.
![]() MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | Finance |
Mitsubishi Tanabe Pharma Corp.
![]() Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |